BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Javelot H. [Psychopharmacology of anxiety and depression: Historical aspects, current treatments and perspectives]. Ann Pharm Fr 2016;74:93-118. [PMID: 26472602 DOI: 10.1016/j.pharma.2015.09.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Henter ID, de Sousa RT, Zarate CA Jr. Glutamatergic Modulators in Depression. Harv Rev Psychiatry 2018;26:307-19. [PMID: 29465478 DOI: 10.1097/HRP.0000000000000183] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 8.7] [Reference Citation Analysis]
2 Garay RP, Zarate CA Jr, Charpeaud T, Citrome L, Correll CU, Hameg A, Llorca PM. Investigational drugs in recent clinical trials for treatment-resistant depression. Expert Rev Neurother 2017;17:593-609. [PMID: 28092469 DOI: 10.1080/14737175.2017.1283217] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 8.2] [Reference Citation Analysis]
3 Javelot H, Dizet S, Straczek C, Langrée B, Michel B, Haffen E, Bertschy G. Enhancing the role played by clinical pharmacists in psychiatric settings to better integrate clinical psychopharmacology into the decision-making process. Therapie 2021;76:149-56. [PMID: 33358640 DOI: 10.1016/j.therap.2020.12.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Wang YT, Wang XL, Feng ST, Chen NH, Wang ZZ, Zhang Y. Novel rapid-acting glutamatergic modulators: Targeting the synaptic plasticity in depression. Pharmacol Res 2021;171:105761. [PMID: 34242798 DOI: 10.1016/j.phrs.2021.105761] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]